🇺🇸 FDA

Drug profile · INN

naldemedine tosylate

SYMPROIC

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

naldemedine tosylate (SYMPROIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN naldemedine tosylate
Brand SYMPROIC
Route ORAL
Formulation TABLET

Frequently asked questions

What is naldemedine tosylate?

naldemedine tosylate (SYMPROIC) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for naldemedine tosylate?

SYMPROIC is a marketed brand name for naldemedine tosylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of naldemedine tosylate?

naldemedine tosylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.